Fig. 4
From: SRSF3 functions as an oncogene in colorectal cancer by regulating the expression of ArhGAP30
SRSF3 could serve as a potential therapeutic target in CRC: a, b Knockdown of SRSF3 inhibited growth of xenograft in nude mice; c Tumor volume in the SRSF3 siRNA group and the control group. Knockdown of SRSF3 significantly suppressed xenograft tumor progression. d Immunofluorescence showing knockdown of SRSF3 dramatically decreased the level of ArhGAP30 in xenograft CRC tumors